Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Mini-Clinical Evaluation Exercise Improves Resident Self-Assessment
February 2026
Mini-CEX self-assessment training plus feedback improved dermatology residents’ exam skills and rating alignment well in practice.
Read more
3 Oct 2025
Combined Radiation and Chemotherapy Offer Safer Path in Angiosarcoma
Helical tomotherapy combined with paclitaxel demonstrated encouraging survival outcomes with manageable toxicity in patients with cutaneous angiosarcoma.
1 Oct 2025
Can Biologic Therapy Be Safely Used in HS?
Adalimumab use in patients with hidradenitis suppurativa (HS) appears safe with appropriate prophylaxis, as no cases of hepatitis B virus (HBV) or tuberculosis (TB) reactivation were observed in a large retrospective analysis.
26 Sep 2025
A Step Forward Against Chronic Kidney Disease Itch
Dupilumab may provide meaningful relief for patients with chronic kidney disease who experience uremic pruritus and for those with atopic dermatitis complicated by renal impairment, according to a retrospective real-world study.
24 Sep 2025
Six Months to Better Outcomes in Vitiligo?
Oral JAK inhibitors appear effective and safe in the treatment of vitiligo, according to a retrospective study evaluating real-world outcomes in nearly 100 patients.
19 Sep 2025
Real-World PEDISTAD Study Explores Pediatric Atopic Dermatitis
Children under 12 years with moderate to severe atopic dermatitis experienced varying outcomes with systemic therapies, according to new real-world data from the PEDISTAD registry.
15 Sep 2025
Cutaneous Vasculitis Signals Poor Outcomes in Sjögren Disease
Cutaneous vasculitis in primary Sjögren disease is linked to significantly worse outcomes, particularly when cryoglobulinemic vasculitis is present, according to findings from a large multicenter cohort study.
12 Sep 2025
Emotional Support Fuels Growth in Skin Disorders
Patients with psychophysiological skin disorders such as atopic dermatitis, psoriasis, pruritus, and alopecia experience measurable benefits in post-traumatic growth when they receive emotional and informational support, according to new research.
10 Sep 2025
Scalp Metastases from Breast Cancer Show Distinct Dermoscopic Patterns
Scalp cutaneous metastases from breast carcinoma may present with varied clinical patterns, and new research highlights distinct dermoscopic features that could aid earlier recognition.
Loading posts...
« Previous
1
…
4
5
6
7
8
…
21
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View